Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
---|---|---|---|---|---|
24-Aug-24 | Interim | 34,773.00 | 1,392.00 | 14.59p | 4.25p |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
29-Feb-20 | 58,091.00 | 1,028.00 | 18.60p | 12.3 | 0.4 | +32% | 9.15p | 4.0% |
27-Feb-21 | 57,887.00 | 636.00 | 11.58p | 19.4 | n/a | -38% | 9.15p | 4.1% |
26-Feb-22 | 61,344.00 | 2,033.00 | 22.11p | 13.0 | 0.1 | +91% | 10.90p | 3.8% |
25-Feb-23 | 65,322.00 | 882.00 | 20.71p | 11.9 | n/a | -6% | 10.90p | 4.4% |
24-Feb-24 | 68,187.00 | 2,289.00 | 23.67p | 11.8 | 0.8 | +14% | 12.10p | 4.3% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
28-Feb-25 | 70,033.29 | 3,054.56 | 26.50p | 13.2 | 1.1 | +12% | 13.33p | 0.0% |
28-Feb-26 | 71,703.14 | 3,154.72 | 28.70p | 12.2 | 1.5 | +8% | 14.48p | 0.0% |
28-Feb-27 | 73,320.05 | 3,247.72 | 30.95p | 11.3 | 1.4 | +8% | 15.73p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 12.26 | 11.82 | 13.67 | 1.08 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 350.90p |
Change Today | 2.30p |
% Change | 0.66 % |
52 Week High | 370.60 |
52 Week Low | 273.70 |
Volume | 31,799,411 |
Shares Issued | 6,753m |
Market Cap | £23,696m |
Beta | 0.77 |
RiskGrade | 107 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 5 |
Buy | 8 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 14 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 10-Oct-24 | 16-May-24 |
Paid | 22-Nov-24 | 28-Jun-24 |
Amount | 4.25p | 8.25p |
Time | Volume / Share Price |
16:20 | 2 @ 351.00p |
16:03 | 1 @ 350.20p |
16:03 | 1 @ 350.20p |
15:45 | 9 @ 349.40p |
15:45 | 6 @ 349.40p |
CEO | Ken Murphy |
CFO | Imran Nawaz |
Chair | Gerard Murphy |
You are here: research